New deal to cut ARV costs

NAIROBI, 7 August 2009 (PlusNews) – The Clinton Foundation has announced agreements with two drug companies to bring the cost of second-line antiretrovirals (ARVs) to under US$500 per person annually and reduce the cost of a key tuberculosis (TB) drug to $1 per dose.

“Today’s announcement will help ensure we can sustain treatment over a lifetime, and better treat patients with both HIV and TB, two key steps in turning the tide of the global HIV/AIDS pandemic,” former United States President Bill Clinton said at the Foundation’s headquarters in New York.

Keep reading:  PlusNews: Clinton Foundation closes deal to slash cost of second-line ARVs


~ by h.e.g. on August 9, 2009.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: